Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
|Articles|April 24, 2008
New injection relieves symptoms of Crohn's disease
UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.
Advertisement
Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s
Advertisement
Related to this article
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.
Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.
In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.
A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.
In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration
2
Diabetes Medication Adherence Lags for Black and Hispanic Medicare Patients
3
FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms
4
Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes
5